You are here

  • Home
  • Archive
  • Volume 6, Issue 6
  • Review: pharmacological and non-pharmacological interventions improve outcomes in patients with dementia and for their caregivers

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: pharmacological and non-pharmacological interventions improve outcomes in patients with dementia and for their caregivers

https://doi.org/10.1136/ebm.6.6.183

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    (2001) Neurology 56, 1154. Doody RS, Stevens JC, Beck C, et al.. Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology.. May 8;. :. –66.
    OpenUrlAbstract/FREE Full Text

    
 
 QUESTION: Do pharmacotherapy, educational, or other non-pharmacological interventions improve outcomes in patients with dementia or for their caregivers?

    Data sources

    Studies were identified by searching Medline, EMBASE/Excerpta Medica, CINAHL, Current Contents, Psychological Abstracts, PsycINFO, and the Cochrane databases with terms that include Alzheimer's disease (AD), vascular or multi-infarct dementia, dementia with associated parkinsonian disorder, progressive supranuclear palsy, frontotemporal dementia, and senile dementia. Additional terms used were question specific. Bibliographies of relevant papers were also reviewed.

    Study selection

    Studies were selected if they were randomised controlled trials published in any language or other types of studies published in English with > 20 participants.

    Data extraction

    Data were extracted on study quality, participant characteristics, interventions, outcome measures, and results.

    Main results

    380 articles met the selection criteria. Several studies comparing cholinesterase inhibitors (eg, tacrine, donepezil, tartrate, and galantamine) with placebo showed that these drugs were more effective than placebo for improving cognitive outcomes in a subgroup …

    View Full Text

    Footnotes

    • Source of funding: no external funding.

    • For correspondence: Quality Standards Subcommittee, American Academy of Neurology, 1080 Montreal Avenue, St. Paul, MN 55116, USA. Fax +1 713 798 5326.

    • Abstract and commentary also appear in Evidence-Based Mental Health. A modified version of this abstract appears in Evidence-Based Nursing.